4 terminated, 2 recruiting, 1 completed, 1 withdrawn. 2 Not applicable, 2 Phase 4, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Terminated 1, Withdrawn 1 |
| Phase 4 | 2 | Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Digestive Care, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation Fecal Fat - Exocrine Pancreatic Insuficiency | Recruiting | Digestive Care, Inc. | 30 | 2026-08-03 | 2026-10-27 | |
| Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis Pancreatic Enzyme Replacement Therapy, Placebo, MBT1 - Chronic Pancreatitis, Recurrent Acute Pancreatitis | Phase 4 | Recruiting | Anna Evans Phillips | 80 | 2026-04-20 | 2026-09-11 |
| PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer Pancrelipase, Placebo Oral Capsule - Pancreatic Insufficiency, Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | Massimo Raimondo, M.D. | 16 | 2016-12-01 | 2021-03-15 |
| Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy) ULTRESA, PANCREAZE, CREON - Fibrosing Colonopathy | Terminated | AbbVie | 17 | 2012-07-31 | 2021-03-22 | |
| Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients DCI 1020 - Digestive System Diseases, Pancreatic Disease | Not applicable | Withdrawn | Digestive Care, Inc. | 24 | 2009-02-01 | 2010-05-13 |
| Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control Pancrelipase - Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | Phase 4 | Terminated | Digestive Care, Inc. | 3 | 2008-08-01 | 2013-02-22 |
| Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum) pancrelipase, placebo - Exocrine Pancreatic Insufficiency | Not applicable | Terminated | Digestive Care, Inc. | 11 | 2007-04-01 | 2013-02-22 |
| Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis PANCRECARB® (pancrelipase), Placebo - Cystic Fibrosis, Pancreatic Insufficiency | Phase 3 | Completed | Digestive Care, Inc. | 29 | 2007-01-01 | 2012-02-22 |
Exocrine Pancreatic Insufficiency (8) · Cystic Fibrosis (3) · Pancreatitis, Chronic (2) · Steatorrhea (2) · Alagille Syndrome (1) · Digestive System Diseases (1) · Pancreatic Diseases (1) · Pancreatic Neoplasms (1) · Pancreatitis (1)
Pancrelipase (5)
United States (7)
Anna E Phillips, MD MS (1) · Craig Peterson (1) · Kim Brouwer, PharmD, PhD (1) · Lisa Gangarosa, M.D. (1) · Massimo Raimondo, MD (1) · Michael W Konstan, MD (1) · Tibor Sipos, PhD (1)
R01DK140381 (1)